Navigation Links
Increasing Ice Psychosis

Methamphetamine usage also known as ice has resulted in increasing number of addicts. Health authorities are warning of the increasing number of cases// and they are struggling to deal with the consequences.

Statistics show that about one in four ice addicts have a psychotic episode. Sydney's St Vincent's Hospital has recorded a five-fold increase in patients suffering from ice psychosis. The numbers have surpassed the heroin addicts in Australia.

The reason being that ice is cheaper and more freely available than heroin. The head of emergency at St Vincent's Hospital, Dr Gordian Fulde, told that it takes about six staff members to contain a person affected by ice.

These patients are wild and violent and are the most out of control human beings. He said that it is very different from the other addition drugs such as the normal amphetamines, the old Ritalins etc.

This drug genre is completely different from the others. The head of alcohol and drug services at St Vincent's, Dr Alex Wodak, told that the Federal Government is not aiding the research to find other replacement drugs in place of the ice.

Thereby this could help in treating and reducing the number of ice addict.


'"/>




Page: 1

Related medicine news :

1. Reducing Blood Pressure in Women By Increasing Folate
2. Increasing risk of heart failure for ageing population
3. Condom Vending Machines Increasing Sexual Assaults On Women
4. Increasing Insulin Response In Type 2 Diabetics With New Protein Mixture
5. Artery Stiffness Linked To Increasing Levels Of C-reactive protein
6. Scientists Concerned Over Increasing Malfunction Of Heart Devices
7. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
8. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
9. Sex Health Clinics Unable To Meet Increasing Demand
10. Heart Disease Increasing At An Alarming Rate In New Zealand
11. Childhood Obesity Cause For Increasing Concerns
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Increasing Ice Psychosis

(Date:8/3/2015)... ... August 03, 2015 , ... Catalent Pharma Solutions, the ... and consumer health products, today welcomed the announcement by OPKO Health that the ... for a new treatment for chronic kidney disease (CKD) and vitamin D insufficiency, ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... services to help patients in need. Most people know that general health emergencies, such ... Unfortunately, a fewer amount of people know where to turn to during a dental ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, Inc. today launched the ... as well as announced the date of its next major release. , Version ... management tasks as well as enhancements to the customer experience. Users now ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Physician Leadership ® and Navigant Center for Healthcare Research and Policy Analysis show ... Fifty-five percent of respondents said they agreed or strongly agreed that the controversial ...
(Date:8/3/2015)... NJ (PRWEB) , ... August 03, 2015 , ... ... to announce the development of it’s new program “Designing Secure Healthcare Systems” ... architects, engineers and technology leaders from healthcare organizations with access to the tactics, ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Novatus Unveils Milestone Software Release 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4
... YORK, April 28 Crystal Research Associates, LLC,announced ... Overview(R),(EIO(R)) on BioCurex Inc. (OTC Bulletin Board: BOCX). ... http://www.crystalra.com ., BioCurex, Inc. ("BioCurex" or "the ... diagnosis, imaging, and therapy that target,a global oncology ...
... Establishes Effects of Puzzle ... and Word Games on the Human Body and Mind, ... Carolina,University,s Department of Recreation and Leisure Studies today revealed,the ... measured,the stress-relieving and other mood-lifting effects of so-called "casual",video ...
... drug developed to relieve one of the major side ... approval from the United States Food and Drug Administration ... of opioid-induced bowel disorders in patients receiving palliative care ... FDA,s European equivalent, the Committee for Medicinal Products for ...
... Sylvie Bouchard to Retire from Company -, ... (TSX: DDS;,NASDAQ: DDSS) today announced that Claire Brulle, ... Officer of the Company. Incumbent,Chief Medical Officer Dr. ... on her career practicing medicine., "Dr. Brulle ...
... Available at 1,440 Stores in May 2008, ... Ltd., a medical,device company publicly traded on the ... its RESPeRATE(R) hypertension treatment device,clinically-proven to significantly lower ... the United Kingdom this May through,Lloyds Pharmacy, the ...
... TORONTO, April 28 Readers in Europe and other ... Story, the debut book,from London-born author Shireen Jeejeebhoy. It ... who made medical history as the first,person to live ... The book has just scooped awards in the US ...
Cached Medicine News:Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 2Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 4Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 5Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 6Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 7Health News:Drug developed at the University of Chicago wins FDA approval 2Health News:Drug developed at the University of Chicago wins FDA approval 3Health News:Drug developed at the University of Chicago wins FDA approval 4Health News:Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer 2Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 2Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 3Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 4Health News:Story of Woman's Courage and Medical Innovation Top Choice for Readers 2
(Date:8/3/2015)... -- Biosensors International Group, Ltd. ("Biosensors" or the ... a developer, manufacturer and marketer of innovative medical ... fiscal quarter ended 30 June 2015 ("Q1 FY16"). ... , Biosensors continued to make ... by lower operating expenses and operational improvement. Operating ...
(Date:8/3/2015)... 2015 /OFF HOLD OFF ... PIV757417 The following release: "Biotech Advancements Coupled with ... & Treatments for Critical-Care Patients With Severe Wound ... Aug 2015 12:30 GMT Cooperative research ... research and top-tier universities for identifying biotech solutions ...
(Date:8/3/2015)... BioPharma Inc. (NASDAQ: ARRY ) today reported ... of its fiscal year ended June 30, 2015. ... noted, "Binimetinib and encorafenib, two innovative oncology products ... submissions in 2016. Additional data shared over the ... further validate the value of these programs by ...
Breaking Medicine Technology:Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12
... ITMN ) today announced that it will ... in idiopathic pulmonary fibrosis (IPF) prior,to market open on ... and webcast, with accompanying slide presentation, to discuss results,from ... PST) on Tuesday,February 3. , ...
... MENLO PARK, Calif., Feb. 2 Evalve, Inc., ... percutaneous repair of cardiac valves,announced today the start ... Study of the MitraClip(R) System) study, a continued ... in the United,States as a non-surgical treatment option ...
Cached Medicine Technology:InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3 2First U.S. Patients Enrolled in the REALISM Continued Access Study 2First U.S. Patients Enrolled in the REALISM Continued Access Study 3
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
... HumaPen MEMOIR is the first and only insulin pen ... and amount of your last 16 doses (including priming ... insulin you last took. With HumaPen MEMOIR, you simply ... one-unit increments (up to 60 units) after initial set-up. ...
PulmoLife is a new COPD screening device, designed for quick and easy screening of adult smokers for early detection of COPD....
Medicine Products: